Egenskap
Delayed puberty
Passing the age when puberty normally occurs with no physical or hormonal signs of the onset of puberty.
Sammendrag
- Også kalt
- Delayed pubertal development, Delayed pubertal growth, Pubertal delay
ReferansegenomGRCh38hg38
Posisjoner på gen- og variantsidene følger dette valget i denne nettleseren.
Read the genes linked to Delayed puberty, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test199 gener knyttet til Delayed puberty
Endringer i disse genene forårsaker sjeldne tilstander der Delayed puberty forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| BMP15bone morphogenetic protein 15 | Alltid | I 2 tilstander |
| BTKBruton tyrosine kinase | Alltid | I 1 tilstand |
| DCAF17DDB1 and CUL4 associated factor 17 | Alltid | I 2 tilstander |
| ESR1estrogen receptor 1 | Alltid | I 1 tilstand |
| FAM111BFAM111 trypsin like peptidase B | Alltid | I 1 tilstand |
| GTF3C3general transcription factor IIIC subunit 3 | Alltid | I 1 tilstand |
| HROBhomologous recombination factor with OB-fold | Alltid | I 1 tilstand |
| LEPRleptin receptor | Alltid | I 1 tilstand |
| PRDM13PR/SET domain 13 | Alltid | I 1 tilstand |
| PSMC3IPPSMC3 interacting protein | Alltid | I 2 tilstander |
| RBM28RNA binding motif protein 28 | Alltid | I 2 tilstander |
| RNU2-2RNA, U2 small nuclear 2 | Alltid | I 1 tilstand |
| RNU6ATACRNA, U6atac small nuclear | Alltid | I 1 tilstand |
| SPIDRscaffold protein involved in DNA repair | Alltid | I 2 tilstander |
| TAF13TATA-box binding protein associated factor 13 | Alltid | I 1 tilstand |
| TRA2Btransformer 2 beta homolog | Alltid | I 1 tilstand |
| ZSWIM7zinc finger SWIM-type containing 7 | Alltid | I 2 tilstander |
| ANOS1anosmin 1 | Svært ofte (80–99 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Svært ofte (80–99 %) | I 2 tilstander |
| BNC1basonuclin zinc finger protein 1 | Svært ofte (80–99 %) | I 1 tilstand |
| CCDC141coiled-coil domain containing 141 | Svært ofte (80–99 %) | I 1 tilstand |
| CHD7chromodomain helicase DNA binding protein 7 | Svært ofte (80–99 %) | I 4 tilstander |
| CYB5Acytochrome b5 type A | Svært ofte (80–99 %) | I 1 tilstand |
| CYP11A1cytochrome P450 family 11 subfamily A member 1 | Svært ofte (80–99 %) | I 2 tilstander |
| CYP17A1cytochrome P450 family 17 subfamily A member 1 | Svært ofte (80–99 %) | I 2 tilstander |
| DCCDCC netrin 1 receptor | Svært ofte (80–99 %) | I 1 tilstand |
| DUSP6dual specificity phosphatase 6 | Svært ofte (80–99 %) | I 2 tilstander |
| EMX2empty spiracles homeobox 2 | Svært ofte (80–99 %) | I 2 tilstander |
| FEZF1FEZ family zinc finger 1 | Svært ofte (80–99 %) | I 1 tilstand |
| FGF17fibroblast growth factor 17 | Svært ofte (80–99 %) | I 3 tilstander |
| FGF8fibroblast growth factor 8 | Svært ofte (80–99 %) | I 3 tilstander |
| FGFR1fibroblast growth factor receptor 1 | Svært ofte (80–99 %) | I 3 tilstander |
| FIGLAfolliculogenesis specific bHLH transcription factor | Svært ofte (80–99 %) | I 1 tilstand |
| FLRT3fibronectin leucine rich transmembrane protein 3 | Svært ofte (80–99 %) | I 2 tilstander |
| FSHBfollicle stimulating hormone subunit beta | Svært ofte (80–99 %) | I 1 tilstand |
| FSHRfollicle stimulating hormone receptor | Svært ofte (80–99 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Svært ofte (80–99 %) | I 2 tilstander |
| HESX1HESX homeobox 1 | Svært ofte (80–99 %) | I 3 tilstander |
| HS6ST1heparan sulfate 6-O-sulfotransferase 1 | Svært ofte (80–99 %) | I 2 tilstander |
| IL17RDinterleukin 17 receptor D | Svært ofte (80–99 %) | I 1 tilstand |
Vis 159 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| INSRinsulin receptor | Svært ofte (80–99 %) | I 1 tilstand |
| LMNAlamin A/C | Svært ofte (80–99 %) | I 1 tilstand |
| MRPS22mitochondrial ribosomal protein S22 | Svært ofte (80–99 %) | I 2 tilstander |
| MSH4mutS homolog 4 | Svært ofte (80–99 %) | I 1 tilstand |
| NDNFneuron derived neurotrophic factor | Svært ofte (80–99 %) | I 1 tilstand |
| NR5A1nuclear receptor subfamily 5 group A member 1 | Svært ofte (80–99 %) | I 2 tilstander |
| NUP107nucleoporin 107 | Svært ofte (80–99 %) | I 1 tilstand |
| POLR3ARNA polymerase III subunit A | Svært ofte (80–99 %) | I 2 tilstander |
| POLR3BRNA polymerase III subunit B | Svært ofte (80–99 %) | I 1 tilstand |
| POLR3HRNA polymerase III subunit H | Svært ofte (80–99 %) | I 1 tilstand |
| PROK2prokineticin 2 | Svært ofte (80–99 %) | I 2 tilstander |
| PROKR2prokineticin receptor 2 | Svært ofte (80–99 %) | I 3 tilstander |
| RAB18RAB18, member RAS oncogene family | Svært ofte (80–99 %) | I 1 tilstand |
| RAB3GAP1RAB3 GTPase activating protein catalytic subunit 1 | Svært ofte (80–99 %) | I 1 tilstand |
| RAB3GAP2RAB3 GTPase activating non-catalytic protein subunit 2 | Svært ofte (80–99 %) | I 1 tilstand |
| SCARB2scavenger receptor class B member 2 | Svært ofte (80–99 %) | I 1 tilstand |
| SEMA3Asemaphorin 3A | Svært ofte (80–99 %) | I 1 tilstand |
| SEMA3Esemaphorin 3E | Svært ofte (80–99 %) | I 1 tilstand |
| SLC29A3solute carrier family 29 member 3 | Svært ofte (80–99 %) | I 1 tilstand |
| SOX10SRY-box transcription factor 10 | Svært ofte (80–99 %) | I 1 tilstand |
| SPRY4sprouty RTK signaling antagonist 4 | Svært ofte (80–99 %) | I 2 tilstander |
| TACR3tachykinin receptor 3 | Svært ofte (80–99 %) | I 2 tilstander |
| TBC1D20TBC1 domain family member 20 | Svært ofte (80–99 %) | I 1 tilstand |
| WDR11WD repeat domain 11 | Svært ofte (80–99 %) | I 3 tilstander |
| ARandrogen receptor | Ofte (30–79 %) | I 1 tilstand |
| BRCC3BRCA1/BRCA2-containing complex subunit 3 | Ofte (30–79 %) | I 1 tilstand |
| CDONcell adhesion associated, oncogene regulated | Ofte (30–79 %) | I 1 tilstand |
| CPEcarboxypeptidase E | Ofte (30–79 %) | I 1 tilstand |
| DHX37DEAH-box helicase 37 | Ofte (30–79 %) | I 1 tilstand |
| ENTPD1ectonucleoside triphosphate diphosphohydrolase 1 | Ofte (30–79 %) | I 2 tilstander |
| GALTgalactose-1-phosphate uridylyltransferase | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 1 tilstand |
| GHRgrowth hormone receptor | Ofte (30–79 %) | I 2 tilstander |
| GLAgalactosidase alpha | Ofte (30–79 %) | I 2 tilstander |
| GNRH1gonadotropin releasing hormone 1 | Ofte (30–79 %) | I 2 tilstander |
| GNRHRgonadotropin releasing hormone receptor | Ofte (30–79 %) | I 1 tilstand |
| GPR161G protein-coupled receptor 161 | Ofte (30–79 %) | I 1 tilstand |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Ofte (30–79 %) | I 1 tilstand |
| IGFALSinsulin like growth factor binding protein acid labile subunit | Ofte (30–79 %) | I 2 tilstander |
| KISS1KiSS-1 metastasis suppressor | Ofte (30–79 %) | I 1 tilstand |
| KISS1RKISS1 receptor | Ofte (30–79 %) | I 1 tilstand |
| LHX4LIM homeobox 4 | Ofte (30–79 %) | I 2 tilstander |
| LPIN2lipin 2 | Ofte (30–79 %) | I 1 tilstand |
| MAGEL2MAGE family member L2 | Ofte (30–79 %) | I 4 tilstander |
| MAP3K1mitogen-activated protein kinase kinase kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| MKRN3makorin ring finger protein 3 | Ofte (30–79 %) | I 1 tilstand |
| NDNnecdin, MAGE family member | Ofte (30–79 %) | I 3 tilstander |
| NHLH2nescient helix-loop-helix 2 | Ofte (30–79 %) | I 1 tilstand |
| NONOnon-POU domain containing octamer binding | Ofte (30–79 %) | I 2 tilstander |
| NPAP1nuclear pore associated protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Ofte (30–79 %) | I 3 tilstander |
| NSMFNMDA receptor synaptonuclear signaling and neuronal migration factor | Ofte (30–79 %) | I 1 tilstand |
| OCA2OCA2 melanosomal transmembrane protein | Ofte (30–79 %) | I 3 tilstander |
| POLR3GLRNA polymerase III subunit GL | Ofte (30–79 %) | I 1 tilstand |
| PPP1R15Bprotein phosphatase 1 regulatory subunit 15B | Ofte (30–79 %) | I 2 tilstander |
| PUS1pseudouridine synthase 1 | Ofte (30–79 %) | I 2 tilstander |
| PWAR1Prader Willi/Angelman region RNA 1 | Ofte (30–79 %) | I 1 tilstand |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Ofte (30–79 %) | I 1 tilstand |
| PYGLglycogen phosphorylase L | Ofte (30–79 %) | I 1 tilstand |
| ROBO1roundabout guidance receptor 1 | Ofte (30–79 %) | I 1 tilstand |
| SMPD1sphingomyelin phosphodiesterase 1 | Ofte (30–79 %) | I 1 tilstand |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Ofte (30–79 %) | I 1 tilstand |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Ofte (30–79 %) | I 1 tilstand |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Ofte (30–79 %) | I 3 tilstander |
| SOX11SRY-box transcription factor 11 | Ofte (30–79 %) | I 1 tilstand |
| SOX9SRY-box transcription factor 9 | Ofte (30–79 %) | I 1 tilstand |
| SRYsex determining region Y | Ofte (30–79 %) | I 2 tilstander |
| STAT1signal transducer and activator of transcription 1 | Ofte (30–79 %) | I 2 tilstander |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 2 tilstander |
| TAC3tachykinin precursor 3 | Ofte (30–79 %) | I 1 tilstand |
| TBX3T-box transcription factor 3 | Ofte (30–79 %) | I 2 tilstander |
| TRMT10AtRNA methyltransferase 10A | Ofte (30–79 %) | I 2 tilstander |
| VAMP7vesicle associated membrane protein 7 | Ofte (30–79 %) | I 1 tilstand |
| VPS13Bvacuolar protein sorting 13 homolog B | Ofte (30–79 %) | I 2 tilstander |
| WFS1wolframin ER transmembrane glycoprotein | Ofte (30–79 %) | I 2 tilstander |
| WT1WT1 transcription factor | Ofte (30–79 %) | I 1 tilstand |
| WWOXWW domain containing oxidoreductase | Ofte (30–79 %) | I 1 tilstand |
| YARS2tyrosyl-tRNA synthetase 2 | Ofte (30–79 %) | I 1 tilstand |
| ZBTB20zinc finger and BTB domain containing 20 | Ofte (30–79 %) | I 1 tilstand |
| ZFPM2zinc finger protein, FOG family member 2 | Ofte (30–79 %) | I 1 tilstand |
| AIPAHR interacting HSP90 co-chaperone | Noen ganger (5–29 %) | I 1 tilstand |
| ALX4ALX homeobox 4 | Noen ganger (5–29 %) | I 1 tilstand |
| ATAD3AATPase family AAA domain containing 3A | Noen ganger (5–29 %) | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Noen ganger (5–29 %) | I 1 tilstand |
| BRD4bromodomain containing 4 | Noen ganger (5–29 %) | I 1 tilstand |
| CARS1cysteinyl-tRNA synthetase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| CDH23cadherin related 23 | Noen ganger (5–29 %) | I 2 tilstander |
| CISD2CDGSH iron sulfur domain 2 | Noen ganger (5–29 %) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Noen ganger (5–29 %) | I 1 tilstand |
| COL7A1collagen type VII alpha 1 chain | Noen ganger (5–29 %) | I 2 tilstander |
| CTNNB1catenin beta 1 | Noen ganger (5–29 %) | I 1 tilstand |
| DACT1dishevelled binding antagonist of beta catenin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| DIAPH1diaphanous related formin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| EIF5Aeukaryotic translation initiation factor 5A | Noen ganger (5–29 %) | I 1 tilstand |
| EXT2exostosin glycosyltransferase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| FOXA2forkhead box A2 | Noen ganger (5–29 %) | I 1 tilstand |
| GHSRgrowth hormone secretagogue receptor | Noen ganger (5–29 %) | I 1 tilstand |
| GLI2GLI family zinc finger 2 | Noen ganger (5–29 %) | I 1 tilstand |
| HBBhemoglobin subunit beta | Noen ganger (5–29 %) | I 2 tilstander |
| HDAC8histone deacetylase 8 | Noen ganger (5–29 %) | I 1 tilstand |
| MAP3K7mitogen-activated protein kinase kinase kinase 7 | Noen ganger (5–29 %) | I 1 tilstand |
| MAU2MAU2 sister chromatid cohesion factor | Noen ganger (5–29 %) | I 1 tilstand |
| MEN1menin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MMP1matrix metallopeptidase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| MT-ATP8mitochondrially encoded ATP synthase membrane subunit 8 | Noen ganger (5–29 %) | I 1 tilstand |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NDPnorrin cystine knot growth factor NDP | Noen ganger (5–29 %) | I 1 tilstand |
| NF1neurofibromin 1 | Noen ganger (5–29 %) | I 1 tilstand |
| NIPBLNIPBL cohesin loading factor | Noen ganger (5–29 %) | I 1 tilstand |
| NLRP3NLR family pyrin domain containing 3 | Noen ganger (5–29 %) | I 1 tilstand |
| NOTCH2notch receptor 2 | Noen ganger (5–29 %) | I 1 tilstand |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Noen ganger (5–29 %) | I 1 tilstand |
| OTX2orthodenticle homeobox 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PCSK1proprotein convertase subtilisin/kexin type 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PGM1phosphoglucomutase 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PHF21APHD finger protein 21A | Noen ganger (5–29 %) | I 1 tilstand |
| PHKA2phosphorylase kinase regulatory subunit alpha 2 | Noen ganger (5–29 %) | I 1 tilstand |
| PHKG2phosphorylase kinase catalytic subunit gamma 2 | Noen ganger (5–29 %) | I 1 tilstand |
| POMCproopiomelanocortin | Noen ganger (5–29 %) | I 1 tilstand |
| PORcytochrome p450 oxidoreductase | Noen ganger (5–29 %) | I 1 tilstand |
| POU1F1POU class 1 homeobox 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PROP1PROP paired-like homeobox 1 | Noen ganger (5–29 %) | I 2 tilstander |
| PTRH2peptidyl-tRNA hydrolase 2 | Noen ganger (5–29 %) | I 2 tilstander |
| RAD21RAD21 cohesin complex component | Noen ganger (5–29 %) | I 1 tilstand |
| RAI1retinoic acid induced 1 | Noen ganger (5–29 %) | I 1 tilstand |
| RPL10ribosomal protein L10 | Noen ganger (5–29 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Noen ganger (5–29 %) | I 1 tilstand |
| SALL1spalt like transcription factor 1 | Noen ganger (5–29 %) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Noen ganger (5–29 %) | I 2 tilstander |
| SLC37A4solute carrier family 37 member 4 | Noen ganger (5–29 %) | I 3 tilstander |
| SMC1Astructural maintenance of chromosomes 1A | Noen ganger (5–29 %) | I 1 tilstand |
| SMC3structural maintenance of chromosomes 3 | Noen ganger (5–29 %) | I 1 tilstand |
| SOX3SRY-box transcription factor 3 | Noen ganger (5–29 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Noen ganger (5–29 %) | I 1 tilstand |
| TGFB1transforming growth factor beta 1 | Noen ganger (5–29 %) | I 2 tilstander |
| TRIP4thyroid hormone receptor interactor 4 | Noen ganger (5–29 %) | I 1 tilstand |
| USP9Xubiquitin specific peptidase 9 X-linked | Noen ganger (5–29 %) | I 1 tilstand |
| ZFXzinc finger protein X-linked | Noen ganger (5–29 %) | I 1 tilstand |
| ZMPSTE24zinc metallopeptidase STE24 | Noen ganger (5–29 %) | I 1 tilstand |
| SPTBN1spectrin beta, non-erythrocytic 1 | Sjelden (1–4%) | I 1 tilstand |
| ALDOAaldolase, fructose-bisphosphate A | Ikke registrert | I 1 tilstand |
| CENPTcentromere protein T | Ikke registrert | I 1 tilstand |
| CTNScystinosin, lysosomal cystine transporter | Ikke registrert | I 1 tilstand |
| CUL4Bcullin 4B | Ikke registrert | I 1 tilstand |
| EIF2S3eukaryotic translation initiation factor 2 subunit gamma | Ikke registrert | I 1 tilstand |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Ikke registrert | I 1 tilstand |
| G6PC1glucose-6-phosphatase catalytic subunit 1 | Ikke registrert | I 1 tilstand |
| GMNNgeminin DNA replication inhibitor | Ikke registrert | I 1 tilstand |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Ikke registrert | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Ikke registrert | I 1 tilstand |
| LGR4leucine rich repeat containing G protein-coupled receptor 4 | Ikke registrert | I 1 tilstand |
| LHBluteinizing hormone subunit beta | Ikke registrert | I 1 tilstand |
| MSMO1methylsterol monooxygenase 1 | Ikke registrert | I 1 tilstand |
| PHF6PHD finger protein 6 | Ikke registrert | I 1 tilstand |
| PNPLA6patatin like domain 6, lysophospholipase | Ikke registrert | I 1 tilstand |
| POF1BPOF1B actin binding protein | Ikke registrert | I 1 tilstand |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Ikke registrert | I 1 tilstand |
| TCF12transcription factor 12 | Ikke registrert | I 1 tilstand |
| TGFB2transforming growth factor beta 2 | Ikke registrert | I 1 tilstand |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Smalere egenskaper
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker